Non-steroidal anti-inflammatory drugs in Alzheimer disease;Anti-inflammatoires non steroidiens et maladie d'Alzheimer

Presse Medicale

Volumn 27, Issue 1, 1998, Pages 25-28

  Nourhashemi F ^a   Ousset, P J ^a   Reyes, G ^a   Micas, M ^a   Adoue, D ^a   Vellas, B J ^a   Albarede J L ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEMENTIA; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; REVIEW; ARTICLE; FEMALE; MALE; RHEUMATOID ARTHRITIS;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE;

EID: 0031952439     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scan 1987 ; 76:465-79.
2. Aisen PS, Kenneth LD. Inflammatory mechanisms in Alzheimer's diseases: Implication for therapy. Am J Psychiatry 1994 ; 151:1105-13.
3. Perlmutter LS, Barron E, Chui HC. Morphologic association between microglia and senile plaque amyloid in Alzheimer disease. Neurosci Lett 1990 ; 119:32-6.
4. Itagaki S, McGeer PL, Akiyama H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer disease brain tissue. Neurosci Lett 1988 ; 91:259-64.
5. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR in human microglia is dependent on clinical and technical factors. Am J Pathol 1990 ; 136:1101-14.
6. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989 ; 86:7611-15.
7. Dickson DW, Mattiace LA, Yen SH. Interleukin-1 (IL-1), interteukin-6 (IL-6) and tumor necrosis factor (TNF) immunoreactivities are expressed in microglia in human brain. Soc Neurosci (Abstr) 1990 ; 16:1267.
8. McGeer PL, Akiyama H, Itagaki S et al. Immune system response in Alzheimer disease. Can J Neural Sci 1989 ; 16:516-27.
9. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992 ; 42:447-9.
10. Heyman A, Wilkinson WE, Stafford JA et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984 ; 15:335-41.
11. French LR, Schuman LM, Mortimer JA et al. A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985 ; 121:414-21.
12. Broe GA, Henderson AS, Creasey H et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990 ; 40:1698-707.
13. Li C, Shen YC, Chen CH et al. A case control study of Alzheimer's disease in China. Neurology 1992 ; 42:1481-2.
14. The Canadian Study of Health and Aging. Risk factors for Alzheimer's disease in Canada. Neurology 1994 ; 44:2073-80.
15. Breitner JCS, Gau BA, Welsh KA et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of co-twin control study. Neurology 1994 ; 44:227-32.
16. Graves AB, White E, Koepsell TD et al. A case-control study of Alzheimer's disease. Ann Neurol 1990 ; 28:766-74.
17. Jenkinson ML, Bliss MR, Brain AT et al. Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol 1989 ; 28:86-8.
18. McGeer PL, McGeer E, Rogers J et al. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990 ; 335:1037.
19. Beard CM, Kokman E, Kurland LT. Rheumatoid arthritis and susceptibility to Alzheimer's disease. Lancet 1991 ; 337:1426.
20. Myllykangas-Luosujarvi R, Isomaki H. Alzheimer's disease and rheumatoid arthritis. Br J Rheumatol 1994 ; 53:501-2.
21. Andersen K, Launer LJ, Ott A et al. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995 ; 45:1441-5.
22. Rich JB, Rasmusson DX, Folstein MF et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995 ; 45:51-5.
23. Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, Reuning-Scherer J, Culanski B. The Alzheimer's disease assessment scale: Patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 1997 ; 48:1511-17.
24. Corrada M, Stewart W, Kawas C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. Neurology 1996 ; 46:A433.
25. Rozzini R, Ferrucci L, Losonczy K et al. Protective effect of chronic NSAID use on cognitive decline in older persons. J Am Geriatr Soc 1996 ; 44:1025-9.
26. Stewart WF, Kawas C, Corrada M et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997 ; 48:626-32.
27. Rogers J, Kirby LC, Hempelman SR et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993 ; 43:1609-11.
28. Bruce-Jones PNE, Crome P, Kalra L. Indomethacin and cognitive function in healthy elderly volunteers. Br J Clin Pharmac 1994 ; 38:45-51.